Antibody Drug Conjugate (ADC) Market Key Highlights and Future Opportunities Till 2035
The antibody drug conjugates market, valued at USD 15.47 billion in 2025, is projected to reach USD 18.57 billion in 2026 and USD 43.56 billion by 2035, representing a CAGR of 9.9% during the forecast period 2026 to 2035. Market growth is expected to be supported by the expanding global oncology therapeutics landscape, increasing commercialization of targeted cancer therapies, sustained industry investment, and the rising adoption of advanced treatment modalities across healthcare systems.
For more details on the market, please visit the following URL: https://www.rootsanalysis.com/....reports/antibody-dru